share_log

美股异动 | Aptose Biosciences(APTO.US)涨超64%，获奥本海默上调目标价至9美元

智通財經 ·  Mar 24, 2021 23:15

The Zhitong Finance App learned that on Thursday, Aptose Biosciences (APTO.US) stock price rose. As of 23:16 Beijing time, the stock had risen more than 64% to 6.058 US dollars. Oppenheimer raised the target price of Aptose Biosciences from $8 to $9.

Aptose Biosciences is a clinical-stage biopharmaceutical company that discovers and develops personalized therapies in the US to address unmet medical needs in oncology.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment